首页>
外国专利>
Treatment of symptomatic benign prostatic hyperplasia
Treatment of symptomatic benign prostatic hyperplasia
展开▼
机译：症状性前列腺增生症的治疗
展开▼
页面导航
摘要
著录项
相似文献
摘要
Use of potassium iodide, administered orally, in an average daily dosage of 0.10 to 0.40 milligrams for the treatment of symptomatic Benign Prostatic Hyperplasia. The potassium iodide preferably is used in the form of a saturated aqueous solution of potassium iodide.
展开▼
